Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasmodium falciparum non-circumsporozoite (non-CSP) sporozoite surface proteins are a collection of antigens found on the surface of the malaria parasite during the sporozoite stage, distinct from the dominant circumsporozoite protein (Source: PubMed PMC6060606). This group includes critical proteins such as Thrombospondin-related anonymous protein (TRAP), Cell-traversal protein for ookinetes and sporozoites (CelTOS), and the 6-cys family proteins P36 and P52 (Source: UniProt P17072, PubMed 21903655). These molecules facilitate essential biological processes including gliding motility, traversal through host skin and endothelial cells, and the specific recognition and invasion of hepatocytes (Source: PubMed 17513740). In the context of drug and vaccine development, these proteins are targeted to prevent the parasite from establishing a liver-stage infection, which is a prerequisite for the symptomatic blood-stage of malaria (Source: NIH/NIAID). While CSP-based vaccines like RTS,S/AS01 have reached implementation, non-CSP proteins are being explored as next-generation targets or as components of multi-antigen vaccines to provide broader and more durable protection (Source: WHO Malaria Vaccine Technology Roadmap). Therapeutic strategies include the use of viral-vectored vaccines to induce T-cell responses and monoclonal antibodies to neutralize parasite movement and entry (Source: PubMed 30038374).
Inhibition of gliding motility and blockade of hepatocyte invasion through antibody-mediated neutralization or T-cell-mediated clearance of infected cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum non-circumsporozoite sporozoite surface proteins (Non-CSP SSPs).